Van Eck Associates Corp Guardant Health, Inc. Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Guardant Health, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 1,958 shares of GH stock, worth $62,009. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,958

Previous 2,855 31.42%

Holding current value

$62,009

Previous $82,000 51.22%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$22.3 - $36.29 $20,003 - $32,552	-897 Reduced 31.42%	1,958 $40,000
Q2 2024 Jul 31, 2024	SELL	$16.07 - $31.84 $1,333 - $2,642	-83 Reduced 2.83%	2,855 $82,000
Q1 2024 Apr 30, 2024	BUY	$17.13 - $26.91 $4,042 - $6,350	236 Added 8.73%	2,938 $60,000
Q4 2023 Feb 05, 2024	BUY	$21.58 - $29.5 $13,250 - $18,113	614 Added 29.41%	2,702 $73,000
Q3 2023 Nov 08, 2023	BUY	$25.8 - $39.97 $4,824 - $7,474	187 Added 9.84%	2,088 $62,000
Q2 2023 Aug 03, 2023	BUY	$20.94 - $38.01 $5,318 - $9,654	254 Added 15.42%	1,901 $68,000
Q1 2023 May 03, 2023	SELL	$22.92 - $33.76 $1.91 Million - $2.82 Million	-83,518 Reduced 98.07%	1,647 $39,000
Q4 2022 Feb 08, 2023	BUY	$25.44 - $59.78 $330,033 - $775,525	12,973 Added 17.97%	85,165 $2.32 Million
Q3 2022 Oct 27, 2022	SELL	$43.66 - $61.0 $1.17 Million - $1.64 Million	-26,851 Reduced 27.11%	72,192 $3.89 Million
Q2 2022 Aug 03, 2022	BUY	$28.82 - $77.35 $50,233 - $134,821	1,743 Added 1.79%	99,043 $4 Million
Q1 2022 May 10, 2022	SELL	$48.25 - $100.49 $1.41 Million - $2.94 Million	-29,217 Reduced 23.09%	97,300 $6.45 Million
Q4 2021 Jan 26, 2022	SELL	$88.71 - $120.43 $458,896 - $622,984	-5,173 Reduced 3.93%	126,517 $12.7 Million
Q3 2021 Nov 03, 2021	SELL	$98.77 - $132.17 $2.46 Million - $3.3 Million	-24,942 Reduced 15.92%	131,690 $16.5 Million
Q2 2021 Aug 10, 2021	BUY	$109.77 - $165.68 $914,493 - $1.38 Million	8,331 Added 5.62%	156,632 $19.5 Million
Q1 2021 May 13, 2021	BUY	$127.04 - $179.1 $334,877 - $472,107	2,636 Added 1.81%	148,301 $22.6 Million
Q4 2020 Feb 09, 2021	BUY	$99.96 - $135.93 $778,888 - $1.06 Million	7,792 Added 5.65%	145,665 $18.8 Million
Q3 2020 Nov 12, 2020	BUY	$80.32 - $111.8 $112,367 - $156,408	1,399 Added 1.03%	137,873 $15.4 Million
Q2 2020 Aug 10, 2020	BUY	$60.49 - $97.5 $2.78 Million - $4.49 Million	46,031 Added 50.9%	136,474 $11.1 Million
Q1 2020 May 12, 2020	SELL	$59.04 - $88.81 $483,183 - $726,821	-8,184 Reduced 8.3%	90,443 $6.3 Million
Q4 2019 Feb 13, 2020	BUY	$59.49 - $82.78 $663,670 - $923,493	11,156 Added 12.75%	98,627 $7.71 Million
Q3 2019 Nov 08, 2019	BUY	$62.59 - $110.3 $5.47 Million - $9.65 Million	87,471 New	87,471 $5.58 Million

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.24B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Guardant Health, Inc. Transaction History